InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Andrews Ronald Asbury, Director. Insider active across 3 companies, notably Precipio, Inc.. Aggregated, 16 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €96k. History available since 7 May 2021. The latest transaction was disclosed on 15 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Andrews Ronald Asbury
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
922 股Common StockSEC:0001193125-26-292654:0
568 股@ US$17.580.018% mcap50.0% 占其流量Common StockSEC:0001104659-26-005081:0
568 股@ US$17.5810.4% 占其流量Common StockSEC:0001104659-25-100104:0
676 股@ US$14.7811.6% 占其流量Common StockSEC:0001104659-25-069057:0
1,785 股@ US$5.6012.0% 占其流量Common StockSEC:0001104659-25-036085:0
1,639 股@ US$6.1013.1% 占其流量Common StockSEC:0001104659-25-004156:0
1,510 股@ US$6.6212.4% 占其流量Common StockSEC:0001104659-24-109550:0
2,157 股@ US$4.6312.4% 占其流量Common StockSEC:0001104659-24-080213:0
3,153 股@ US$6.6626.8% 占其流量Common StockSEC:0001104659-24-048320:0
4,005 股Common StockSEC:0001104659-23-111758:0
6,060 股Common StockSEC:0001104659-23-100810:0
250,000 股0Common Stock, no par valueSEC:0001493152-22-035089:0
40,000 股@ US$0.9639.2% 占其流量Common Stock, no par valueSEC:0001493152-22-023462:0
标准退出：2022年11月14日 (T+90)
50,000 股@ US$1.283100.0% 占其流量Common Stock, no par valueSEC:0001493152-22-007205:0
标准退出：2022年6月14日 (T+90)
65,000 股0Common Stock, no par valueSEC:0001493152-21-016130:0
106,221 股0Common Stock, no par valueSEC:0001493152-21-015984:0
16 条申报中的 16 条
About Andrews Ronald Asbury
Ronald Asbury Andrews serves as Chief Executive Officer and Director at Precipio, Inc. and OncoCyte Corp. He leads the strategic operations of both companies, focusing on growth and innovation. Ronald has extensive experience in the sector, enabling him to effectively guide teams toward achieving organizational goals. His leadership is essential for the future development of the companies.
